Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib
2017; Elsevier BV; Volume: 1; Issue: 26 Linguagem: Inglês
10.1182/bloodadvances.2017011999
ISSN2473-9537
AutoresAlexander P. Bye, Amanda J. Unsworth, Michael Desborough, Catherine Hildyard, Niamh Appleby, David Bruce, Neline Kriek, Sophie H. Nock, Tanya Sage, Craig E. Hughes, Jonathan M. Gibbins,
Tópico(s)Chronic Myeloid Leukemia Treatments
Referência(s)